Phase 1/2Completed
Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial
- Sponsor
- Steadman Philippon Research Institute (Academic or other)
- Enrolment
- 75 enrolled
- Conditions
- Osteoarthritis, Knee
- Interventions
- Fisetin; Placebo oral capsule
- Ages
- adults, older adults
- Registry
- NCT04210986
From the registry
Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis
Primary outcomes
- Number of Participants Experiencing One or More Treatment-Emergent Adverse Event